Log In
Sign Up
PhD Student
Fully Funded PhD Scholarship (Spring/Fall 2026) Full-time
Fully Funded PhD Scholarship (Spring/Fall 2026) at Nanyang Technological University, Singapore
[AI for Drug Discovery and Multi-Modal Large Language Models for Biomedical Science]
Join us at the cutting edge of innovation with a Ph.D. position dedicated to pioneering deep learning technologies in drug discovery and biomedical sciences. This opportunity invites you to be a key player in a team pushing the boundaries of what artificial intelligence can achieve in medical science.
What makes our group unique is the integration of an AI team with an experimental wet lab team, working hand-in-hand to translate computational discoveries into real drug development. This dual strength allows us to rapidly test, validate, and iterate AI-designed therapeutics in the lab, creating an unparalleled environment to conduct meaningful and translational research.
What We’re Looking For:
We seek driven individuals who are ready to thrive in a fast-paced, intellectually rich environment. Your background may be in any of the following fields:
- Computer Science
- Mathematics
- Machine Learning
- Physics
- Biomedical Engineering
- Biochemistry
- Biology
The Ideal Candidate’s Experience Includes:
- Proficiency in Machine Learning/Deep Learning
- Knowledge of Large Language Models
- Python programming skills
Application Process:
If you’re ready to contribute to groundbreaking research at the intersection of AI and medicine, we want to hear from you. Please submit your curriculum vitae, transcripts, and a brief description of your research interests and experiences to Dr. Alvin Chan at [Please click the Apply button for the link or address].
This PhD scholarship at Nanyang Technological University, Singapore, is not just a path to academic and professional growth—it’s your chance to be part of meaningful research that redefines the future of medicine through AI. Join us in our mission to create innovative solutions for the most pressing medical challenges of our time.